AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitamerz M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Tms India Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitamerz M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney failure and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo may be used alone or with other diabetes treatments, and is most effective when paired with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering your health status, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes benefits; discontinue only under physician guidance. Adherence to your doctor's diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, vomiting, diarrhea, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is possible if you also use insulin or sulfonylureas; learn to identify and manage this risk. This medication isn't for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic issues, or significant alcohol consumption before starting. Pregnant or nursing individuals should seek medical advice. Interaction with other drugs is possible; disclose all medications to ensure safety. Alcohol should be limited due to its blood sugar-lowering effect. Your physician will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitamerz M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitamerz M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Ingestion of the Sitamerz M 50mg/500mg Tablet should coincide with a meal.

Common Side effects of Sitamerz M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitamerz M 50mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Sitamerz M 50mg/500mg Tablet with a meal.

How Sitamerz M 50mg/500mg Tablet works:

Sitagliptin/metformin 50mg/500mg tablets (Sitamerz M) combine two diabetes medications to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitamerz M 50mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitamerz M 50mg/500mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitamerz M 50mg/500mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitamerz M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. The medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Sitamerz M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitamerz M 50mg/500mg Tablet :

Should you forget to take a Sitamerz M 50mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitamerz M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitamerz M 50mg/500mg Tablet

Sitamerz M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Prolonged use of Sitamerz M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and urinary issues), and cognitive changes, including balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitamerz M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitamerz M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitamerz M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Sitagliptin + Metformin (Sitamerz M 50mg/500mg Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitamerz M and seek immediate medical attention.
Sitamerz M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitamerz M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitamerz M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitamerz M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitamerz M 50mg/500mg) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitamerz M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitamerz M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitamerz M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitamerz M 50mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamerz M 50mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (Sitamerz M 50mg/500mg) can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitamerz M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitamerz M 50mg/500mg Tab...
194